Skip to content
Friedreich's Ataxia News logo
  • Forums
  • About FA
    What is FA?
    Causes
    Symptoms
    • Cardiomyopathy
    Diagnosis
    Treatments
    • Approved treatment: Skyclarys
    • Experimental Treatments
    • Non-drug Treatments
  • News
  • Columns
    Defining Yourself — Jean Walsh
    My Darling Disability
    — Kendall Harvey
    Little Victories — Matthew Lafleur
    Recalibrating – Elizabeth Hamilton
    Archived Columns
    • No Good Excuse — Sean Baumstark
    • Hope from Home — Katie Griffith
    • An Unexpected Journey — David Riley
    • Practical Guide to Life with FA — Christina Cordaro
  • FA education
    Videos: Start strong, stay steady
    My FA diagnosis story
    Growing up with FA
    Talking to your child about FA
    Assistive equipment, aids, and adaptations
    Guidance for parents of children with FA
    FA treatment options
    Exercise and physiotherapy
    Living with FA
    FA support and resources
    FA and mental health
    Essential travel tips
    Speech therapy
    AAC devices
    Occupational therapy
    FA and diet
    Late-onset FA
    Aging with FA
  • Find a physician
  • For professionals
  • Advocacy partners
  • What can we help you find today?

    • Forums

Differences in pediatric vs. adult-onset Friedreich's ataxia

Sub Subramony, MD, discusses how Friedreich’s ataxia onset and progression affects pediatric populations differently from adults, and how this impacts treatment.

About Sub Subramony, MD

Sub Subramony, MD, is a board-certified neurologist and neuromuscular medicine specialist at the Norman Fixel Institute for Neurological Diseases at University of Florida Health. He also serves as a professor in the University of Florida Department of Neurology with a joint appointment in pediatrics. His area of focus is genetic neuromuscular diseases, including Friedreich’s ataxia.

Transcript

Friedreich’s ataxia is typically a disease of children beginning in around 9, 10, 11 years of age or even 12. But there is a substantial number that affects — begins the process in — adult life anywhere from 20, 30, 40 years of age as well.

In children, in general, the earlier the onset of the disease, the faster the progression. And they tend to decline faster.

And again, the earlier onset is related to the fact that the repeat expansion, the GAA expansion, is of a larger size and that leads to earlier onset, whereas with the later onset disease, the expansion size tends to be smaller.

Though there is no strict correlation, you cannot predict the age of onset looking at the expansion size in a blood test. But what it also means is that the larger expansions are also associated with some of the other things that happens in Friedreich’s ataxia. Cardiomyopathy, for example, often is more common in patients with larger expansions.

So we know, for example, that many patients with Friedreich’s ataxia who begin in childhood have a greater likelihood of having a cardiomyopathy, typically what we call a hypertrophic cardiomyopathy, which is an enlargement of the muscle thickness of the heart in various regions, like the septal wall and the posterior wall thickness, it goes up.

This tends to be less likely in adult-onset disease as well. Now, obviously a lot of the children will eventually grow up into adults, so they’ll carry on with all the problems that are associated with childhood onset of the disease.

So, again, you need more monitoring and more careful management of multiple problems in children, which is less definitely of an issue in adults, but nevertheless all of these patients require multidisciplinary care.

Our FA medical advisor

Dr. David LynchDavid Lynch, MD, PhD, is the director of the Friedreich’s Ataxia Program at Children’s Hospital of Philadelphia.

Meet the expert

Newsletter driver

Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

This field is for validation purposes and should be left unchanged.

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 All rights reserved.